Загрузка страницы

Xofigo | How It Works, Side Effects, and More | Ask a Prostate Expert, Mark Scholz, MD | PCRI

PCRI's Alex and Dr. Scholz discuss Xofigo (radium-223), an injectible radioligand therapy used to treat extensive bone metastases when there are no visceral (organ) metastases and limited lymph node metastases.

0:06 How does Xofigo work? In what stage of prostate cancer is it used?

1:28 What is the patient experience of receiving treatment with Xofigo?

2:08 Should patients be taking any supplementary treatments with Xofigo?

2:59 Can Xofigo treat any type of metastatic lesion?

3:38 Does Xofigo affect PSA?

4:22 What is the response rate of Xofigo?

6:10 Based on the current standard of care, where does Xofigo fit into the current sequence of treatments?

7:13 Are there any negative drug interactions with Xofigo?

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

Видео Xofigo | How It Works, Side Effects, and More | Ask a Prostate Expert, Mark Scholz, MD | PCRI канала Prostate Cancer Research Institute
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
26 февраля 2021 г. 22:00:00
00:08:19
Другие видео канала
Immune Therapy: Future Game Changers In Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDImmune Therapy: Future Game Changers In Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDSigns and Symptoms of Prostate Cancer,  Dr. Mark Litwin | UCLAMDChatSigns and Symptoms of Prostate Cancer, Dr. Mark Litwin | UCLAMDChatWhat Is a Normal PSA for a Man Without Prostate Cancer? | Ask a Prostate Expert, Mark Scholz, MDWhat Is a Normal PSA for a Man Without Prostate Cancer? | Ask a Prostate Expert, Mark Scholz, MDWhat Is the Role Chemotherapy in Modern Day Prostate Cancer Treatment? | Evan Yu, MD Explains | PCRIWhat Is the Role Chemotherapy in Modern Day Prostate Cancer Treatment? | Evan Yu, MD Explains | PCRIFive Uses for MRI In Prostate Cancer | Prostate Cancer Staging GuideFive Uses for MRI In Prostate Cancer | Prostate Cancer Staging GuideDoes Sugar Feed Prostate Cancer? Does Fatty/Adipose Tissue Attract Cancer? | Mark Moyad, MD, MPHDoes Sugar Feed Prostate Cancer? Does Fatty/Adipose Tissue Attract Cancer? | Mark Moyad, MD, MPHBone Metastasis: Treatments, Scans & Side Effects | Ask a Prostate Expert, Mark Scholz, MDBone Metastasis: Treatments, Scans & Side Effects | Ask a Prostate Expert, Mark Scholz, MDTreatments Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDTreatments Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDProton Therapy Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging GuideProton Therapy Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging GuideFocal Therapy: Eligibility, Treatments, & Side Effects | Ask a Prostate Expert, Mark Scholz, MDFocal Therapy: Eligibility, Treatments, & Side Effects | Ask a Prostate Expert, Mark Scholz, MDHIFU is FDA Approved, but Should You Get It? We ask Prostate Expert, Mark Scholz, MDHIFU is FDA Approved, but Should You Get It? We ask Prostate Expert, Mark Scholz, MDImpact of Lifestyle and Exercise on Prostate Cancer, Mark Moyad, MD, MPH | 2018 PCRI ConferenceImpact of Lifestyle and Exercise on Prostate Cancer, Mark Moyad, MD, MPH | 2018 PCRI ConferenceHormone Therapy & Radiation for Prostate Cancer | We Answer Your Youtube Questions | The PCRIHormone Therapy & Radiation for Prostate Cancer | We Answer Your Youtube Questions | The PCRIProstate Cancer Staging   Mark Scholz, MDProstate Cancer Staging Mark Scholz, MDHigh-Risk Prostate Cancer: Hormone Therapy after Surgery | Ask a Prostate Expert, Mark Scholz, MDHigh-Risk Prostate Cancer: Hormone Therapy after Surgery | Ask a Prostate Expert, Mark Scholz, MDStories of Advanced Prostate Cancer Remissions | Ask a Prostate Cancer Expert, Mark Scholz, MDStories of Advanced Prostate Cancer Remissions | Ask a Prostate Cancer Expert, Mark Scholz, MDLutetium-177 and Bipolar Androgen Therapy: Future Game Changers In Prostate Cancer | PCRILutetium-177 and Bipolar Androgen Therapy: Future Game Changers In Prostate Cancer | PCRIHormone Therapy & Advanced Therapies for Prostate Cancer, Celestia Higano, MD | 2021 Mid-Year UpdateHormone Therapy & Advanced Therapies for Prostate Cancer, Celestia Higano, MD | 2021 Mid-Year UpdateUnexpected Responses to Prostate Cancer Treatments | 2019 PCRI ExcerptsUnexpected Responses to Prostate Cancer Treatments | 2019 PCRI ExcerptsGleason 4+4=8 Prostate Cancer Treatments | Ask a Prostate Expert, Mark Scholz, MDGleason 4+4=8 Prostate Cancer Treatments | Ask a Prostate Expert, Mark Scholz, MD
Яндекс.Метрика